Dissertation title: Healthcare costs in relation to body mass index in over 1 million women
College (year of matriculation): Lincoln College (2014)
Supervisors: Dr Ben Cairns, Dr Boby Mihaylova
Seamus Kent is a National Institute for Health Research (NIHR) Doctoral Research Fellow studying the impact of overweight and obesity on long-term health and healthcare resource use and costs using the Million Women Study and linked administrative data sets. Seamus is affiliated with both the Cancer Epidemiology Unit and the Health Economics Research Centre.
Seamus joined the Nuffield Department of Population Health in 2012 to develop health economics research using data from two large contemporary clinical trials, HPS2-THRIVE and SHARP. His research focused on estimating the impacts of adverse events, demographic characteristics and common risk factors on healthcare costs and health-related quality of life in populations at increased cardiovascular disease risk, and, in the case of SHARP, a population with chronic kidney disease.
Seamus graduated with a BSc in Economics in 2009 and was awarded an MSc in Health Economics at the University of York in 2010 and an MSc in Medical Statistics at the University of Leicester in 2013.
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)
Mihaylova B. et al, (2015), American Journal of Kidney Diseases
Mapping from the Parkinson's Disease Questionnaire PDQ-39 to the Generic EuroQol EQ-5D-3L: The Value of Mixture Models.
Kent S. et al, (2015), Med Decis Making, 35, 902 - 911
A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation
Lewsey JD. et al, (2015), Heart, 101, 201 - 208
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
Kent S. et al, (2015), BMC Nephrol, 16
Are value of information methods ready for prime time? An application to alternative treatment strategies for NSTEMI patients.
Kent S. et al, (2013), Int J Technol Assess Health Care, 29, 435 - 442